{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:01:38Z","timestamp":1787320898354,"version":"build-2736575974"},"reference-count":94,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0237534","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T15:03:51Z","timestamp":1597417431000},"page":"e0237534","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Unfavorable outcomes to second-line tuberculosis therapy among HIV-infected versus HIV-uninfected patients in sub-Saharan Africa: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-5829","authenticated-orcid":true,"given":"Dumessa","family":"Edessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6611-1174","authenticated-orcid":true,"given":"Mekonnen","family":"Sisay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadeta","family":"Dessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"pone.0237534.ref001","article-title":"Tuberculosis (TB)","author":"TE Herchline","year":"2019","journal-title":"Medscape"},{"key":"pone.0237534.ref002","unstructured":"World Health Organization: Tuberculosis: key facts. World Health Organization, Geneva, Switzerland http:\/\/wwwwhoint\/news-room\/fact-sheets\/detail\/tuberculosis Accessed 2018, 5."},{"issue":"11","key":"pone.0237534.ref003","doi-asserted-by":"crossref","first-page":"281","DOI":"10.15585\/mmwr.mm6911a2","article-title":"Global Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets\u2014Worldwide, 2018","volume":"69","author":"A MacNeil","year":"2020","journal-title":"MMWR Morbidity and mortality weekly report"},{"key":"pone.0237534.ref004","unstructured":"WHO: Global tuberculosis 2019 report. 2019."},{"key":"pone.0237534.ref005","unstructured":"WHO: World Tuberculosis Day 2019; In: Tuberculosis: Africa region Office report."},{"key":"pone.0237534.ref006","first-page":"9","article-title":"Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives","volume":"12","author":"A Singh","year":"2020","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"pone.0237534.ref007","unstructured":"UNAIDS: MDR-TB more common in people living with HIV. 2008."},{"key":"pone.0237534.ref008","unstructured":"WHO: Drug-resistant TB In: Global tuberculosis report. 2014."},{"key":"pone.0237534.ref009","doi-asserted-by":"crossref","unstructured":"World Health Organization: WHO consolidated guidelines on drug-resistant tuberculosis treatment. 2019.","DOI":"10.4103\/ijmr.IJMR_579_19"},{"key":"pone.0237534.ref010","volume-title":"WHO treatment guidelines for drug-resistant tuberculosis","author":"WHO","year":"2016"},{"issue":"1","key":"pone.0237534.ref011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12879-020-4887-1","article-title":"Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study","volume":"20","author":"LH Van","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0237534.ref012","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12879-019-3931-5","article-title":"Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study","volume":"19","author":"M El Hamdouni","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"12","key":"pone.0237534.ref013","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(18)30550-4","article-title":"Occult rifampicin-resistant tuberculosis: better assays are needed","volume":"18","author":"E Variava","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0237534.ref014","unstructured":"WHO: Definitions and reporting framework for tuberculosis\u2013 2013 revision. 2013."},{"issue":"1","key":"pone.0237534.ref015","first-page":"4","article-title":"Treatment outcomes of the drug resistant tuberculosis cases previously exposed to second line anti Tuberculosis drugs in Pakistan: A multi-center cross-sectional study","volume":"69","author":"R Batool","year":"2019","journal-title":"JPMA The Journal of the Pakistan Medical Association"},{"key":"pone.0237534.ref016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijid.2019.02.010","article-title":"Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: A retrospective cohort study","volume":"81","author":"M Yunusbaeva","year":"2019","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"9728","key":"pone.0237534.ref017","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"K Dheda","year":"2010","journal-title":"The Lancet"},{"issue":"6","key":"pone.0237534.ref018","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/COH.0000000000000503","article-title":"Treatment of drug-resistant tuberculosis among people living with HIV","volume":"13","author":"RM Hurtado","year":"2018","journal-title":"Current opinion in HIV and AIDS"},{"key":"pone.0237534.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"5","key":"pone.0237534.ref020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"D Moher","year":"2010","journal-title":"International journal of surgery (London, England)"},{"key":"pone.0237534.ref021","volume-title":"Joanna Briggs Institute Reviewer's Manual","author":"S Moola","year":"2017"},{"key":"pone.0237534.ref022","doi-asserted-by":"crossref","first-page":"105844","DOI":"10.1016\/j.rmed.2019.105844","article-title":"Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements","volume":"161","author":"A Piubello","year":"2020","journal-title":"Respir Med"},{"issue":"2","key":"pone.0237534.ref023","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5588\/ijtld.14.0369","article-title":"Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa","volume":"19","author":"M Loveday","year":"2015","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"10","key":"pone.0237534.ref024","doi-asserted-by":"crossref","first-page":"e46943","DOI":"10.1371\/journal.pone.0046943","article-title":"Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho","volume":"7","author":"H Satti","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"pone.0237534.ref025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/thoraxjnl-2015-207374","article-title":"Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia\u2014an observational cohort study","volume":"70","author":"D Meressa","year":"2015","journal-title":"Thorax"},{"key":"pone.0237534.ref026","author":"OA Adewumi","year":"2012","journal-title":"Treatment outcomes in patients infected with multidrug resistant tuberculosis and in patients with multidrug resistant tuberculosis coinfected with human immunodeficiency virus at Brewelskloof Hospital"},{"key":"pone.0237534.ref027","volume-title":"Time to sputum culture conversion of Multidrug-Resistant tuberculosis in HIV positive versus HIV negative patients in Lesotho","author":"OJ Alakaye","year":"2018"},{"issue":"3","key":"pone.0237534.ref028","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/tmi.12826","article-title":"Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia","volume":"22","author":"KA Alene","year":"2017","journal-title":"Trop Med Int Health"},{"issue":"3","key":"pone.0237534.ref029","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5588\/ijtld.16.0661","article-title":"Outcomes from the first multidrug-resistant tuberculosis programme in Kenya","volume":"21","author":"H Huerga","year":"2017","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"1","key":"pone.0237534.ref030","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1186\/s12889-019-7838-2","article-title":"Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study","volume":"19","author":"DB Ketema","year":"2019","journal-title":"BMC Public Health"},{"key":"pone.0237534.ref031","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3569018","article-title":"Predictors of treatment outcomes among multidrug resistant tuberculosis patients in Tanzania","volume":"2019","author":"TH Leveri","year":"2019","journal-title":"Tuberculosis research and treatment"},{"issue":"2","key":"pone.0237534.ref032","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s15010-013-0572-2","article-title":"Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa","volume":"42","author":"E Marais","year":"2014","journal-title":"Infection"},{"key":"pone.0237534.ref033","author":"KW Mengistu","year":"2019","journal-title":": Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia"},{"issue":"7","key":"pone.0237534.ref034","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/trstmh\/trv037","article-title":"Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa","volume":"109","author":"E Mohr","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"pone.0237534.ref035","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/cid\/cix1125","article-title":"Improved Survival and Cure Rates with Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa","volume":"66","author":"JCM Brust","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"pone.0237534.ref036","doi-asserted-by":"crossref","first-page":"e20436","DOI":"10.1371\/journal.pone.0020436","article-title":"Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.","volume":"6","author":"JE Farley","year":"2011","journal-title":"PLoS One"},{"key":"pone.0237534.ref037","volume-title":"Clinical characteristics and treatment outcomes of multi-drug resistant tuberculosis patients attending a hospital in Buffalo City Metropolitan Municipality, Eastern Cape","author":"O Jikijela","year":"2018"},{"issue":"1","key":"pone.0237534.ref038","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0000000000001169","article-title":"High treatment success rates among HIV-infected multidrug-resistant tuberculosis patients after expansion of antiretroviral therapy in Botswana, 2006\u20132013","volume":"74","author":"SS Shin","year":"2017","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"4","key":"pone.0237534.ref039","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5588\/ijtld.13.0742","article-title":"Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.","volume":"18","author":"H Cox","year":"2014","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"12","key":"pone.0237534.ref040","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/INF.0000000000001691","article-title":"Treatment Outcomes of Children With HIV Infection and Drug-resistant TB in Three Provinces in South Africa, 2005\u20132008","volume":"36","author":"EW Hall","year":"2017","journal-title":"The Pediatric infectious disease journal"},{"key":"pone.0237534.ref041","volume-title":"Treatment outcomes in patients infected with multidrug resistant tuberculosis and in patients with multidrug resistant tuberculosis coinfected with human immunodeficiency virus at Brewelskloof Hospital","author":"OA Adewumi","year":"2012"},{"issue":"5","key":"pone.0237534.ref042","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2753.2008.00986.x","article-title":"Interpretation of tests of heterogeneity and bias in meta\u2010analysis","volume":"14","author":"JP Ioannidis","year":"2008","journal-title":"Journal of evaluation in clinical practice"},{"issue":"8","key":"pone.0237534.ref043","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1503\/cmaj.060410","article-title":"The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey","volume":"176","author":"JP Ioannidis","year":"2007","journal-title":"Cmaj"},{"issue":"1","key":"pone.0237534.ref044","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5588\/ijtld.17.0498","article-title":"Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries","volume":"22","author":"A Trebucq","year":"2018","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"1","key":"pone.0237534.ref045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s12879-019-4317-4","article-title":"Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis","volume":"19","author":"ED Chem","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"Suppl 2","key":"pone.0237534.ref046","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.5588\/pha.14.0042","article-title":"Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of Belarus","volume":"4","author":"A Khaliaukin","year":"2014","journal-title":"Public Health Action"},{"issue":"9","key":"pone.0237534.ref047","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/trstmh\/trx074","article-title":"High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012\u20132014: a retrospective cohort study","volume":"111","author":"MK Thu","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"pone.0237534.ref048","doi-asserted-by":"crossref","first-page":"e0202469","DOI":"10.1371\/journal.pone.0202469","article-title":"Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013","volume":"13","author":"R Chingonzoh","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"pone.0237534.ref049","doi-asserted-by":"crossref","first-page":"e000351","DOI":"10.1136\/bmjopen-2011-000351","article-title":"Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study","volume":"1","author":"Y Balabanova","year":"2011","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0237534.ref050","article-title":"High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam","volume":"5","author":"LTN Anh","year":"2020","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"pone.0237534.ref051","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12879-017-2230-2","article-title":"Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine","volume":"17","author":"O Aibana","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"5","key":"pone.0237534.ref052","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1183\/09031936.00155708","article-title":"Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB","volume":"33","author":"K Kliiman","year":"2009","journal-title":"The European respiratory journal"},{"issue":"2","key":"pone.0237534.ref053","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1164\/ajrccm.160.2.9901012","article-title":"Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study","volume":"160","author":"M Flament-Saillour","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0237534.ref054","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12879-017-2810-1","article-title":"Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis","volume":"17","author":"ML Bastos","year":"2017","journal-title":"BMC infectious diseases"},{"issue":"12","key":"pone.0237534.ref055","doi-asserted-by":"crossref","first-page":"e28066","DOI":"10.1371\/journal.pone.0028066","article-title":"Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India","volume":"6","author":"P Isaakidis","year":"2011","journal-title":"PLoS One"},{"key":"pone.0237534.ref056","unstructured":"WHO: MULTIDRUG RESISTANT TUBERCULOSIS (MDR-TB) 2017 update. 2017."},{"key":"pone.0237534.ref057","article-title":"Treatment Complexities Among Patients with Tuberculosis in a High HIV Prevalence Cohort in the United States","author":"DJ Bizune","year":"2018","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9456","key":"pone.0237534.ref058","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(05)70196-3","article-title":"Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study","volume":"365","author":"V Leimane","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"pone.0237534.ref059","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijtb.2016.02.003","article-title":"Scaling up of HIV-TB collaborative activities: Achievements and challenges in India","volume":"63","author":"R Deshmukh","year":"2016","journal-title":"The Indian journal of tuberculosis"},{"key":"pone.0237534.ref060","first-page":"525","volume-title":"Seminars in respiratory and critical care medicine: 2008","author":"WM El-Sadr"},{"issue":"2","key":"pone.0237534.ref061","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.lpm.2017.01.017","article-title":"The cursed duet today: Tuberculosis and HIV-coinfection","volume":"46","author":"S Tiberi","year":"2017","journal-title":"Presse medicale (Paris, France: 1983)"},{"issue":"9","key":"pone.0237534.ref062","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/tmi.12146","article-title":"'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis","volume":"18","author":"P Isaakidis","year":"2013","journal-title":"Trop Med Int Health"},{"issue":"7","key":"pone.0237534.ref063","doi-asserted-by":"crossref","first-page":"e0219322","DOI":"10.1371\/journal.pone.0219322","article-title":"Multinomial modelling of TB\/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state","volume":"14","author":"FJ Duffy","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"pone.0237534.ref064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193491","article-title":"Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study","volume":"13","author":"M Bastard","year":"2018","journal-title":"PloS one"},{"issue":"4","key":"pone.0237534.ref065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1469-0691.2003.00547.x","article-title":"Treatment outcome of tuberculosis among Saudi nationals: role of drug resistance and compliance","volume":"9","author":"Y Samman","year":"2003","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"5","key":"pone.0237534.ref066","doi-asserted-by":"crossref","first-page":"e0126267","DOI":"10.1371\/journal.pone.0126267","article-title":"Integrating Community-Based Interventions to Reverse the Convergent TB\/HIV Epidemics in Rural South Africa","volume":"10","author":"JA Gilbert","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0237534.ref067","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1186\/s12889-019-7965-9","article-title":"Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa","volume":"19","author":"L Jamieson","year":"2019","journal-title":"BMC Public Health"},{"issue":"4","key":"pone.0237534.ref068","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bjid.2018.07.002","article-title":"Predictors of mortality in multidrug-resistant tuberculosis patients from Brazilian reference centers, 2005 to 2012","volume":"22","author":"R Gayoso","year":"2018","journal-title":"The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases"},{"issue":"1","key":"pone.0237534.ref069","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1186\/s12879-019-4709-5","article-title":"Urban-rural disparities in treatment outcomes among recurrent TB cases in Southern Province, Zambia","volume":"19","author":"S Mutembo","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"11","key":"pone.0237534.ref070","doi-asserted-by":"crossref","first-page":"e0225165","DOI":"10.1371\/journal.pone.0225165","article-title":"Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria","volume":"14","author":"M Bajehson","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"pone.0237534.ref071","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tube.2012.06.003","article-title":"Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects","volume":"92","author":"EV Kurbatova","year":"2012","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"issue":"Suppl 3","key":"pone.0237534.ref072","first-page":"7","article-title":"Risk of Death among HIV Co-Infected Multidrug Resistant Tuberculosis Patients, Compared To Mortality in the General Population of South Africa","author":"SO Manda","year":"2013","journal-title":"J AIDS Clin Res"},{"issue":"4","key":"pone.0237534.ref073","first-page":"413","article-title":"High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000\u20132003","volume":"14","author":"JC Brust","year":"2010","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"1","key":"pone.0237534.ref074","first-page":"45","article-title":"Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam","volume":"10","author":"HT Quy","year":"2006","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"8","key":"pone.0237534.ref075","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/cid\/cix1125","article-title":"Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa","volume":"66","author":"JCM Brust","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0237534.ref076","doi-asserted-by":"crossref","first-page":"e0144249","DOI":"10.1371\/journal.pone.0144249","article-title":"Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000\u20132008, South Africa","volume":"11","author":"M van der Walt","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"pone.0237534.ref077","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1164\/ajrccm.153.1.8542137","article-title":"Outcome of MDR-TB patients, 1983\u20131993. Prolonged survival with appropriate therapy","volume":"153","author":"MM Park","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"pone.0237534.ref078","doi-asserted-by":"crossref","first-page":"e68869","DOI":"10.1371\/journal.pone.0068869","article-title":"Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India","volume":"8","author":"P Isaakidis","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"pone.0237534.ref079","doi-asserted-by":"crossref","first-page":"e0128907","DOI":"10.1371\/journal.pone.0128907","article-title":"Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study","volume":"10","author":"J Gadoev","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"pone.0237534.ref080","doi-asserted-by":"crossref","first-page":"e0193491","DOI":"10.1371\/journal.pone.0193491","article-title":"Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study","volume":"13","author":"M Bastard","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"pone.0237534.ref081","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.medmal.2019.02.007","article-title":"Factors of loss to follow-up during tuberculosis treatment in a low-incidence region","volume":"50","author":"M Tetart","year":"2020","journal-title":"Medecine et maladies infectieuses"},{"issue":"4","key":"pone.0237534.ref082","first-page":"266","article-title":"[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000\u20132003)]","volume":"66","author":"B Chevalier","year":"2010","journal-title":"Revue de pneumologie clinique"},{"issue":"4","key":"pone.0237534.ref083","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2196\/jmir.9.4.e29","article-title":"Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas","volume":"9","author":"HS Fraser","year":"2007","journal-title":"Journal of medical Internet research"},{"issue":"1","key":"pone.0237534.ref084","doi-asserted-by":"crossref","first-page":"1568826","DOI":"10.1080\/16549716.2019.1568826","article-title":"Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study","volume":"12","author":"P Thekkur","year":"2019","journal-title":"Global health action"},{"issue":"11","key":"pone.0237534.ref085","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.5588\/ijtld.16.0111","article-title":"Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study","volume":"20","author":"A Daftary","year":"2016","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"1","key":"pone.0237534.ref086","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12879-016-1933-0","article-title":"Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study","volume":"16","author":"K Schnippel","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pone.0237534.ref087","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.anl.2016.10.005","article-title":"Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy","volume":"44","author":"OA Sogebi","year":"2017","journal-title":"Auris, nasus, larynx"},{"issue":"3","key":"pone.0237534.ref088","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/dkh377","article-title":"Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?","volume":"54","author":"G Di Perri","year":"2004","journal-title":"Journal of Antimicrobial chemotherapy"},{"issue":"9","key":"pone.0237534.ref089","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.5588\/ijtld.12.0037","article-title":"Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis","volume":"16","author":"K Bl\u00f6ndal","year":"2012","journal-title":"The International journal of tuberculosis and lung disease"},{"issue":"10","key":"pone.0237534.ref090","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/14740338.2016.1216544","article-title":"Adverse effects of oral second-line antituberculosis drugs in children","volume":"15","author":"HS Schaaf","year":"2016","journal-title":"Expert opinion on drug safety"},{"issue":"9407","key":"pone.0237534.ref091","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(04)15496-2","article-title":"Programmes and principles in treatment of multidrug-resistant tuberculosis","volume":"363","author":"JS Mukherjee","year":"2004","journal-title":"The Lancet"},{"key":"pone.0237534.ref092","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.ijmyco.2016.07.003","article-title":"Individualized treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring","volume":"5","author":"MS Bolhuis","year":"2016","journal-title":"International journal of mycobacteriology"},{"issue":"1","key":"pone.0237534.ref093","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00002030-199701000-00016","article-title":"Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand","volume":"11","author":"J Ngamvithayapong","year":"1997","journal-title":"Aids"},{"issue":"3","key":"pone.0237534.ref094","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1164\/rccm.200911-1768OC","article-title":"Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment","volume":"182","author":"SS Shin","year":"2010","journal-title":"Am J Respir Crit Care Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T15:05:56Z","timestamp":1597417556000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237534"}},"subtitle":[],"editor":[{"given":"Qigui","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":94,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0237534","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}